Such upregulation of FasL in tumor endothelium is stimulated by the secretion of some factors by cancer cells including interleukin-10 (IL-10), prostaglandin E2, and vascular endothelial growth factor-2 (VEGF-2). Here, FASLG is linked to neoplasm.